Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2020
Investigation of the effect of the dual orexin receptor antagonist almorexant on ophthalmological, spermatogenic, and hormonal variables in healthy male subjectsJasper Dingemanse, Pascal Charef, Jed Black, et al.Sleep Medicine|July 21, 2009
The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsyJed Black, Daniel Pardi, Carl S Hornfeldt, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 6, 2011
The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsyJed Black, Daniel Pardi, Carl S Hornfeldt, et al.Sleep Medicine|October 17, 2017
Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybateMilton Erman, Helene Emsellem, Jed Black, et al.Sleep Medicine|November 5, 2016
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexyJed Black, Todd Swick, Richard Bogan, et al.CNS Spectrums|February 6, 2007
Recent advances in the treatment and management of excessive daytime sleepinessJed Black, Stephen P Duntley, Richard K Bogan, et al.Sleep Medicine|January 20, 2024
Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architectureThomas Roth, Yves Dauvilliers, Richard K Bogan, et al.Sleep|June 22, 2007
Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month studyMartin B Scharf, Jed Black, Steven Hull, et al.Sleep|April 2, 2017
Eating Decisions Based on Alertness Levels After a Single Night of Sleep Manipulation: A Randomized Clinical TrialDaniel Pardi, Matthew Buman, Jed Black, et al.Sleep Medicine|December 24, 2014
A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexyMortimer Mamelak, Todd Swick, Helene Emsellem, et al.Pageof 7